Mechanisms Controlling Theophylline Release from Ethanol-Resistant Coated Pellets

被引:0
作者
Y. Rosiaux
C. Velghe
S. Muschert
R. Chokshi
B. Leclercq
F. Siepmann
J. Siepmann
机构
[1] Univ. Lille Nord de France,College of Pharmacy
[2] INSERM U 1008,undefined
[3] Controlled Drug Delivery Systems and Biomaterials,undefined
[4] FMC BioPolymer,undefined
[5] FMC BioPolymer,undefined
[6] 801 Princeton South Corp Ctr,undefined
来源
Pharmaceutical Research | 2014年 / 31卷
关键词
diffusion; ethanol; film coating; mathematical modeling; pellets;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:731 / 741
页数:10
相关论文
共 134 条
[1]  
Rosiaux Y(2013)Ethanol-resistant polymeric film coatings for controlled drug delivery J Control Release 169 1-9
[2]  
Muschert S(2008)Impairment of the in vitro release behaviour of oral modified release preparations in the presence of alcohol Int J Pharm 360 171-6
[3]  
Chokshi R(2007)The effect of ethanol on the release of opioids from oral prolonged-release preparations Drug Dev Ind Pharm 33 1101-11
[4]  
Leclercq B(2007)Influence of ethanol on aspirin release from hypromellose matrices Int J Pharm 332 31-7
[5]  
Siepmann F(2008)Influence of alcohol on the release of tramadol from 24-h controlled-release formulations during in vitro dissolution experiments Drug Dev Ind Pharm 34 885-9
[6]  
Siepmann J(2009)Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation Int J Pharm 368 72-5
[7]  
Fadda HM(2009)Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations Mol Pharm 6 1429-40
[8]  
Mohamed MAM(2010)Effect of ethanol on the water permeability of controlled release films composed of ethyl cellulose and hydroxypropyl cellulose Eur J Pharm Biopharm 76 428-32
[9]  
Basit AW(2010)In vitro dissolution of oral modified-release tablets and capsules in ethanolic media Int J Pharm 398 93-6
[10]  
Walden M(2003)Alcohol use self report in chronic back pain—relationships to psychosocial factors, function performance, and medication use Disabil Rehabil 25 1271-7